These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 20969957)

  • 1. Synaptic dysfunction in genetic models of Parkinson's disease: a role for autophagy?
    Plowey ED; Chu CT
    Neurobiol Dis; 2011 Jul; 43(1):60-7. PubMed ID: 20969957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What genetics tells us about the causes and mechanisms of Parkinson's disease.
    Corti O; Lesage S; Brice A
    Physiol Rev; 2011 Oct; 91(4):1161-218. PubMed ID: 22013209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of genetic research on our understanding of Parkinson's disease.
    Martin I; Dawson VL; Dawson TM
    Prog Brain Res; 2010; 183():21-41. PubMed ID: 20696313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of autophagy in Parkinson's disease.
    Lynch-Day MA; Mao K; Wang K; Zhao M; Klionsky DJ
    Cold Spring Harb Perspect Med; 2012 Apr; 2(4):a009357. PubMed ID: 22474616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Functions of LRRK2 in Parkinson's Disease.
    Jeong GR; Lee BD
    Cells; 2020 Nov; 9(12):. PubMed ID: 33266247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2.
    Belluzzi E; Greggio E; Piccoli G
    Biochem Soc Trans; 2012 Oct; 40(5):1111-6. PubMed ID: 22988874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights into the neurobiology underlying LRRK2-linked Parkinson's disease.
    Gómez-Suaga P; Fdez E; Fernández B; Martínez-Salvador M; Blanca Ramírez M; Madero-Pérez J; Rivero-Ríos P; Fuentes JM; Hilfiker S
    Neuropharmacology; 2014 Oct; 85():45-56. PubMed ID: 24863040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.
    Daher JP
    Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology and pathogenesis of Parkinson disease.
    Schapira AH
    Neurol Clin; 2009 Aug; 27(3):583-603, v. PubMed ID: 19555823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson's Disease.
    Lamonaca G; Volta M
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis of Parkinson disease: insights from genetic studies.
    Gasser T
    Expert Rev Mol Med; 2009 Jul; 11():e22. PubMed ID: 19631006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy.
    Yakhine-Diop SM; Bravo-San Pedro JM; Gómez-Sánchez R; Pizarro-Estrella E; Rodríguez-Arribas M; Climent V; Aiastui A; López de Munain A; Fuentes JM; González-Polo RA
    Toxicology; 2014 Oct; 324():1-9. PubMed ID: 25017139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the pathogenesis of Parkinson's disease.
    Schulz JB
    J Neurol; 2008 Sep; 255 Suppl 5():3-7. PubMed ID: 18787877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the genetics of Parkinson's disease.
    Gasser T
    Mov Disord; 2007 Sep; 22 Suppl 17():S343-50. PubMed ID: 18175395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic mutations in Parkinson disease.
    Tan EK; Skipper LM
    Hum Mutat; 2007 Jul; 28(7):641-53. PubMed ID: 17385668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.